IP Library Granted Patent US 11,028,119
Granted Patent B2
US 11,028,119 · App. 16/717,811 · Granted Jun 8, 2021

Synthetic route to 2′-deoxy-2′,2′-difluorotetrahydrouridines

Inventors: Hyeong-wook Choi (Andover, MA); Steven Mathieu (Windham, NH); Frank Fang (Andover, MA); Bryan Matthew Lewis (North Brunswick, NJ)
Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
C07H19/06C07B57/00C07H1/00C07H1/06C07H19/04C07B2200/07C07H17/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,028,119
App. No.
16/717,811
Granted
Jun 8, 2021
Kind
B2
Abstract

The present invention relates to methods and intermediates for synthesizing 2′-deoxy-2′,2′-difluorotetrahydrouridine compounds.

Claims (24)

1. A method of producing compound 1:

or a salt thereof;

comprising the steps of:

(a) hydrogenating the starting compound of Formula IV:

wherein R is a hydroxyl protecting group,

to produce the compound of Formula IIa:

(b) reducing the compound of Formula IIa to produce the compound of Formula IIIa:

(c) deprotecting the compound of Formula IIIa to produce compound 2:

and

(d) precipitating or crystallizing compound 2 in the presence of a catalyst to produce compound 1:

or a salt thereof;

wherein the catalyst is 1,8-diazabicyclo(5.4.0)undec-7-ene (DBU), acetic acid, trifluoroacetic acid, diisopropylethylamine, or ammonium hydroxide; and

wherein the hydrogenating in step (a) is carried out in the presence of a palladium catalyst.

2. The method of claim 1 , wherein the catalyst is about 1 mol % to about 20 mol % DBU.

3. The method of claim 2 , wherein the catalyst is about 5 mol % to about 10 mol % DBU.

4. The method of claim 3 , wherein the catalyst is about 5 mol % DBU.

5. The method of claim 1 , wherein the catalyst is acetic acid, trifluoroacetic acid, diisopropylethylamine, or ammonium hydroxide.

6. The method of claim 1 , wherein the final product is recrystallized or slurrified.

7. The method of claim 1 , wherein step (d) is carried out in the presence of a solution comprising acetonitrile.

8. The method of claim 1 , wherein step (d) is carried out in the presence of a solution comprising acetone or tetrahydrofuran.

9. The method of claim 1 , wherein step (b) is carried out in the presence of CeCl 3 .

10. The method of claim 1 , further comprising a step of reducing the particle size of compound 1.

11. The method of claim 10 , wherein the particle size is reduced to about 50 μm or less.

12. The method of claim 1 , wherein the palladium catalyst is palladium on charcoal.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2025
From: OTSUKA PHARMACEUTICAL CO., LTD.
To: TAIHO PHARMACEUTICAL CO., LTD.
Reel/Frame 073115/0640 →
Continuity (4)
Continuation 15813743 · Nov 15, 2017
Continuation 15027022
Provisional Application 61896703 · Oct 29, 2013
Related Publication 20200123189A1 · Apr 23, 2020